Introduction
We are doctors looking after patients with blood disorders and scientists studying blood conditions in the lab. Our aim is to deliver the best expert and compassionate care for patients with blood diseases and patients who need blood cell transfusions. We want to reduce the burden of disease now and in the future, through our research, services, education, outreach and advocacy.
Our group includes international, scientific and clinical leaders. We draw on our combined expertise to carry out research and develop new services. Through our work we aim to:
- Improve the cost-effectiveness of cancer therapies and the outcomes of treatment – by developing new single cell approaches which tailor treatments to individuals. Find out more
- Improve the management of common and rare anaemias – by studying the role of iron and inflammation in anaemic patients, especially those who are elderly, and by developing a new national NHS service for patients with rare inherited red cell disorders. Find out more
- Improve the outcomes of blood cell and blood component transfusions – by using advanced e-tools and carrying out clinical trials to find out what approaches work best. Find out more
- Involve patients and carers in the key steps of our research projects. Find out more
Related websites
Oxford Centre for Haematology website: rdm.ox.ac.uk/och
RDM – HaemBio Biobank pages:
rdm.ox.ac.uk/about/our-clinical-facilities-and-mrc-units/och/haembio
NSSG website: nssg.oxford-haematology.org.uk
Introductory Talk by Haematology and Stem Cells Theme Lead Professor Paresh Vyas
Dr Susie Shapiro discusses research into thrombosis and COVID-19
In this webinar hosted by Thrombosis UK, BRC Haematology and Stem Cells theme researcher Dr Susie Shapiro speaks about her research on thrombosis in relation to COVID-19.
Follow the Oxford Centre for Haematology on Twitter
Researchers are developing the use of a #machinelearning algorithm with the aim of diagnosing #deepveinthrombosis quickly and effectively. @nicola_curry @OxfordHaem #thrombosis #RADAI https://t.co/UXnj0VQNE7
On #WorldCancerResearchDay, Prof @AdamMead_Oxford describes the @Tap_Clin_Trials #PROMISE trial to test new #Plexxikon therapy against #bloodcancer, now open for UK #myelofibrosis patients.💊
@CureLeukaemia @CRUKresearch @CRCTU @OxfordBRC @MRC_WIMM @OxfordCancer @OUHospitals
📢 #Job #SeniorManager role to set up the new Therapy Acceleration Laboratory (TAL) for high-throughput precision medicine clinical trials.
@MRC_WIMM @UniofOxford.Apply by 30 Sept: https://t.co/X0dbwAdOnO
#hiring #recruiting #laboratorymanagement #clinicaltrials #medicalresearch
1. Today is World Chronic Myeloid Leukaemia (CML) Day.
7 years ago, I mutated. In a stem cell, bits of chromosomes 9 & 22 (get the date of CML Day?) broke off and swapped places. This wasn't due to diet, smoking or lifestyle habits, just bad luck.
@bloodcancer_uk
#Cancer
"I was diagnosed with #ChronicMyeloidLeukemia in 2003 and I stopped my treatment with tyrosine kinase inhibitors (TKIs) in 2013. I wish patients now facing CML courage and hope."
https://t.co/QhGjX839aO @LMCfrance
#WCMLDay21 #CML #LMC #AccessIsNeeded
On #worldCMLday we come together to raise awareness of chronic myeloid leukaemia #CML.
#spotleukaemia #BeLeukaemiaAware #WCMLDay21 #AccessIsNeeded
@OxfordCancer @cmlnet @AcuteLeuk @cureleukaemia @LeukaemiaCareUK @LeukUK @CR_UK @CLNurses @BloodCancerUK https://t.co/GW6UccDTLu
